Immucell (ICCC) Short-Term Debt repayments (2019)
Immucell (ICCC) posted Short-Term Debt repayments of $2 million for FY2023.
Powered by 
Analysis
Immucell (ICCC) Short-Term Debt repayments (2019) Analysis & Trends
- Annual Short-Term Debt repayments shows a four-year compound annual growth rate of 41.4% (FY2019 to FY2023).
- The FY2023 figure stands as the lowest annual Short-Term Debt repayments since FY2019.
- Business Quant data shows ICCC's Short-Term Debt repayments at $500,000 in FY2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ST Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 6.45 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Immucell | 95.91 Mn | 73.35 Mn | 2.44 Mn | - |
API Access
Immucell Short-Term Debt repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt-repayments", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();